Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation Trajectories

22 Feb 2023

Abstract excerpt

The latest 2021 WHO classification redefines glioblastoma (GBM) as the hierarchical reporting standard by eliminating glioblastoma, IDH-mutant and only retaining the tumor entity of "glioblastoma, IDH-wild type." Knowing that subclassification of tumors based on molecular features is supposed to facilitate the therapeutic choice and increase the response rate in cancer patients, it is necessary to carry out...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Glioma Diagnosis and Treatment
Share to Neuroinflammation and Neurodegeneration Mechanisms
Share to Single-cell and spatial transcriptomics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 37964983
DOI: 10.1155/2023/2826815

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Novel Molecular Classification Method for Glioblastoma Based on Tumor Cell Differentiation TrajectoriesPMID 37964983Read ↗

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and TherapySemantic proximity Read ↗

Sequential fate-switches in stem-like cells drive the tumorigenic trajectory from human neural stem cells to malignant gliomaSemantic proximity Read ↗

A spatiotemporal cancer cell trajectory underlies glioblastoma heterogeneitySemantic proximity Read ↗

Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspectiveSemantic proximity Read ↗

Glioblastoma cell differentiation trajectory predicts the immunotherapy response and overall survival of patientsSemantic proximity Read ↗

Immunological and Prognostic Role of Cell Differentiation Trajectory Defined Gene Signature in GliomaSemantic proximity Read ↗

Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk modelSemantic proximity Read ↗

Joint analysis of single-cell RNA sequencing and bulk transcriptome reveals the heterogeneity of the urea cycle of astrocytes in glioblastomaSemantic proximity Read ↗

Identification of a single cell-based signature for predicting prognosis risk and immunotherapy response in patients with glioblastomaSemantic proximity Read ↗

Mapping the Stemness Landscape of Glioblastoma to Drive Heterogeneity and Drug Resistance: Bridging Pathological Omics with Prognostic OutcomesSemantic proximity Read ↗

Tumor Heterogeneity and Molecular Characteristics of Glioblastoma Revealed by Single-Cell RNA-Seq Data AnalysisSemantic proximity Read ↗

Longitudinal Characteristics of Glioblastoma in Genome-Wide StudiesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.